Welcome to our dedicated page for Rocket Lab Usa SEC filings (Ticker: RKLB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Rocket Lab Corporation (Nasdaq: RKLB) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a U.S. public company. These documents include current reports on Form 8-K, proxy statements, and other filings that describe material events, governance matters, capital markets activity, and acquisitions.
Rocket Lab’s Form 8-K filings cover topics such as quarterly financial results, executive and director changes, equity offering arrangements, and significant transactions. Examples include reports of results of operations for specific quarters, the adoption of a senior executive cash incentive bonus plan, the establishment of an at-the-market equity offering program under a shelf registration statement, and the completion or announcement of acquisitions such as the purchase of the parent holding company of GEOST LLC and an agreement to acquire all shares of Mynaric AG.
The company’s proxy statement on Form DEF 14A provides detail on board structure, director elections, executive compensation, equity plans, and stockholder voting matters. It also describes the holding company reorganization that made Rocket Lab Corporation the parent of Rocket Lab USA, Inc., and outlines proposals presented to stockholders at the annual meeting.
Through these filings, investors can review information about capital raising (including at-the-market offerings), governance and compensation policies, acquisition terms, and other material corporate events. Real-time updates from EDGAR allow users to see new 8-Ks and related exhibits as they are filed.
Stock Titan’s platform associates these filings with AI-powered summaries that explain the key points of lengthy documents, helping users quickly identify items such as new financing arrangements, changes in leadership, or the structure of significant transactions. Users can also track how Rocket Lab uses registration statements and resale prospectus supplements in connection with share issuances tied to acquisitions.
Rocket Lab Corp (RKLB) Chief Financial Officer Adam Spice reported stock sales in a Form 4 filing. On 11/22/2025, he sold 15,633 shares of common stock in a sell-to-cover transaction at a weighted average price of $40.0247 to satisfy tax withholding from vested restricted stock units. On 11/24/2025, he sold an additional 46,737 shares at a weighted average price of $40.8576 and 257 shares at a weighted average price of $41.3495, also reported as sales.
After these transactions, Spice beneficially owned 1,995,373 Rocket Lab common shares, which includes 111 shares acquired under the company’s 2021 Employee Stock Purchase Plan in transactions exempt under Rule 16b-3. The reported sale prices reflect weighted averages for multiple trades within specified price ranges.
Rocket Lab Corp (RKLB) reported an insider stock transaction by its Chief Operations Officer, Frank Klein. On 11/24/2025, Klein sold 10,430, 31,181, and 171 shares of common stock in three separate transactions at weighted average prices of $40.0247, $40.8576, and $41.3495 per share, respectively.
The filing states these sales were part of a “sell-to-cover” arrangement to satisfy tax withholding obligations related to vesting restricted stock units previously granted to him. After these transactions, Klein beneficially owned 1,274,223 Rocket Lab common shares, held directly.
Rocket Lab Corp (RKLB) reported insider share sales by its SVP General Counsel in a Form 4 filing. On 11/24/2025, the executive sold 7,143, 21,355, and 117 shares of common stock in three separate transactions at weighted average prices of $40.0247, $40.8576, and $41.3495, respectively. These sales were executed as part of a sell-to-cover transaction to satisfy tax withholding obligations related to vesting restricted stock units.
Following these trades, the reporting person directly beneficially owns 461,014 Rocket Lab common shares. The prices reported reflect weighted averages for shares sold in multiple trades within the noted price ranges, and detailed breakdowns are available on request to the company or regulators.
Rocket Lab Corp (RKLB) CEO and Director Peter Beck reported equity awards and related share sales. On 11/15/2025, he was granted 132,426 restricted stock units (RSUs) under the Rocket Lab Corporation 2021 Stock Option and Incentive Plan at a price of $0.0. These RSUs vest over time, with 1/16 vesting on November 22, 2025 and 1/16 on each March 1, May 22, August 22 and November 22 thereafter, subject to his continuous service.
On 11/24/2025, Beck sold 4,707, 14,073 and 77 common shares in three separate transactions as sell-to-cover sales to satisfy tax withholding related to RSU vesting. The weighted average sale prices were $40.0247, $40.8576 and $41.3495, each executed in multiple trades within specified price ranges. After these transactions, he directly owned 902,942 Rocket Lab shares and was also reported as an indirect beneficial owner of 2,500,000 shares held by a family trust.
Rocket Lab Corp director Jon A. Olson reported selling 60,400 shares of Rocket Lab common stock in an open-market transaction on 11/20/2025 at a weighted average price of $45.0244 per share.
Following this sale, Olson directly beneficially owned 375,835 Rocket Lab shares. The filing notes that the reported price is a weighted average, as the shares were sold in multiple trades at prices ranging from $45 to $45.110 per share.
Rocket Lab (RKLB) reported Q3 2025 results with total revenue of $155.1 million, up from $104.8 million a year ago. Gross profit rose to $57.3 million, while operating loss was $59.0 million. A tax benefit drove net loss to $18.3 million, an improvement from a $51.9 million loss in the prior year period.
Liquidity strengthened: cash and cash equivalents reached $807.9 million, supported by $865.5 million in proceeds from at-the-market equity offerings year‑to‑date. Stockholders’ equity increased to $1.28 billion from $382.5 million at year‑end 2024.
GEOST acquisition closed on August 12, adding preliminary identifiable intangibles of $183.3 million and goodwill of $146.7 million. Consideration totaled $289.6 million, including $133.7 million cash and 3,057,588 shares valued at $137.7 million, plus $18.3 million contingent consideration. Q3 included $5.0 million revenue and a $2.1 million operating loss from GEOST.
Backlog was $1.096 billion as of September 30, 2025, with about 57% expected to convert within 12 months. For the nine months, revenue was $422.1 million versus $303.8 million in 2024. As of November 5, 2025, common shares outstanding were 534,156,333.
Rocket Lab Corporation furnished a press release announcing financial results for the third quarter ended September 30, 2025, as Exhibit 99.1 to an 8-K. The Item 2.02 information is furnished and not deemed filed under the Exchange Act.
The company also disclosed that director Matt Ocko notified Rocket Lab of his resignation from the Board, effective November 30, 2025. The filing states his resignation is not due to any dispute or disagreement regarding operations, policies, or practices.
Rocket Lab Corporation is entering the optical communications market more deeply by agreeing to acquire all outstanding shares of German company Mynaric AG. Under the Stock Purchase Agreement, Rocket Lab’s subsidiary will purchase Mynaric for aggregate consideration of $75 million, payable in cash or Rocket Lab common stock at the company’s discretion, subject to closing adjustments. The deal also includes up to an additional $75 million in potential post-closing earnout payments in cash or stock, tied to Mynaric’s revenue performance for 2025, 2026 and 2027.
Any Rocket Lab stock issued in the transaction or as earnout will be valued using the 20-day volume-weighted average price before closing or the earnout payment date. These shares will be issued in a private offering relying on exemptions from SEC registration, and Rocket Lab has committed to file a resale registration statement for such shares within 30 days after closing. Completion of the acquisition is still subject to regulatory approval from the German Ministry of Foreign Affairs.
Adam C. Spice, Rocket Lab Corp (RKLB) Chief Financial Officer, reported option exercises and share sales in mid-September 2025. On 09/18/2025 Mr. Spice exercised an employee stock option with a $1.09 exercise price covering 1,867,496 shares, triggering acquisition of those common shares. The filing reports a subsequent "sell-to-cover" disposition on 09/19/2025 of 862,588 shares at a weighted-average price of $47.9941 and an additional sale of 12,000 shares at a weighted-average price of $48.8484 to satisfy the exercise cost and tax withholding. After these transactions, the reporting person beneficially owned 3,254,155 shares including 1,867,496 underlying the exercised option and 2,057,889 shares held directly following the final sale.
Adam C. Spice, Rocket Lab Corp (RKLB) Chief Financial Officer, reported option exercises and share sales in mid-September 2025. On 09/18/2025 Mr. Spice exercised an employee stock option with a $1.09 exercise price covering 1,867,496 shares, triggering acquisition of those common shares. The filing reports a subsequent "sell-to-cover" disposition on 09/19/2025 of 862,588 shares at a weighted-average price of $47.9941 and an additional sale of 12,000 shares at a weighted-average price of $48.8484 to satisfy the exercise cost and tax withholding. After these transactions, the reporting person beneficially owned 3,254,155 shares including 1,867,496 underlying the exercised option and 2,057,889 shares held directly following the final sale.
Alexander R. Slusky, a director of Rocket Lab Corp (RKLB), reported on Form 4 that on 09/18/2025 he disposed of 35,000 shares of Rocket Lab common stock as a bona fide gift to a charitable entity. After the gift, Mr. Slusky directly beneficially owns 88,849 shares and indirectly owns 534,675 shares through Abalone Cove LLLP, a partnership where he is the sole general partner and, together with his spouse, the sole limited partners. The Form 4 was signed by an attorney-in-fact on 09/22/2025.
Alexander R. Slusky, a director of Rocket Lab Corp (RKLB), reported on Form 4 that on 09/18/2025 he disposed of 35,000 shares of Rocket Lab common stock as a bona fide gift to a charitable entity. After the gift, Mr. Slusky directly beneficially owns 88,849 shares and indirectly owns 534,675 shares through Abalone Cove LLLP, a partnership where he is the sole general partner and, together with his spouse, the sole limited partners. The Form 4 was signed by an attorney-in-fact on 09/22/2025.